Search results

Page title matches

• Rituximab
  In [[medicine]], [[rituximab]] is a [[medication]] that is "a genetically engineered anti-[[CD20 antigen
  257 bytes (31 words) - 01:39, 7 October 2013
• Rituximab/Definition
  204 bytes (30 words) - 10:52, 8 September 2009
• Rituximab/Related Articles
  Auto-populated based on [[Special:WhatLinksHere/Rituximab]]. Needs checking by a human.
  606 bytes (75 words) - 20:04, 11 January 2010

Page text matches

• Rituximab
  In [[medicine]], [[rituximab]] is a [[medication]] that is "a genetically engineered anti-[[CD20 antigen
  257 bytes (31 words) - 01:39, 7 October 2013
• Bronchiolitis obliterans organizing pneumonia/Related Articles
  {{r|Rituximab}}
  509 bytes (63 words) - 11:32, 11 January 2010
• B-Cell chronic lymphocytic leukemia/Related Articles
  {{r|Rituximab}}
  506 bytes (63 words) - 10:21, 1 March 2010
• Rituximab/Related Articles
  Auto-populated based on [[Special:WhatLinksHere/Rituximab]]. Needs checking by a human.
  606 bytes (75 words) - 20:04, 11 January 2010
• Lymphoma/Related Articles
  {{r|Rituximab}}
  647 bytes (82 words) - 18:12, 11 January 2010
• Disease modifying anti-rheumatic drugs/Related Articles
  {{r|Rituximab||**}}
  925 bytes (100 words) - 19:38, 18 September 2010
• B-Cell chronic lymphocytic leukemia
  ...ia<br/>&bull;&nbsp;10% rate of infection during first year<br/>&bull;&nbsp;Rituximab induced fever (37%), chills (50%), hypotension (13%), nausea and vomiting
  4 KB (497 words) - 22:05, 12 June 2010
• Bronchiolitis obliterans organizing pneumonia
  ...rlowski RZ |title=Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma |journal=Hematological oncology |volume=
  2 KB (308 words) - 17:34, 10 February 2024
• Autoimmune hemolytic anemia
  ...Ledochowski S, Durupt S, Michallet AS et al.| title=Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies. | journal=A
  3 KB (477 words) - 12:55, 8 September 2020
• Monoclonal antibody
  * [[Chimeric monoclonal antibody]]. INN names end in -ximab. Example is [[rituximab]].
  2 KB (244 words) - 09:00, 26 April 2014
• 90Y-Ibritumomab Tiuxetan
  '''Day 1:''' The patient receives 250mg/m² [[Rituximab]] intravenously. This is a common drug of chemotherapy. After four hours, t '''Day 7:''' The patient again receives 250mg/m² Rituximab intravenously. After fours hours, the patient receives radioactive <sup>90<
  11 KB (1,563 words) - 03:38, 7 October 2013
• Food and Drug Administration/Related Articles
  {{r|Rituximab}}
  4 KB (505 words) - 16:36, 11 January 2010
• Antineoplastic agent
  ...ntrez protein]) antibody for the treatment of B-cell lymphoma".<ref>{{MeSH|Rituximab [Substance Name]}}</ref>
  10 KB (1,356 words) - 06:07, 5 April 2024
• Antineoplastic agent/Related Articles
  {{r|Rituximab}} is a "genetically engineered anti-CD20 (Entrez protein) antibody for the
  4 KB (467 words) - 00:17, 6 February 2009
• Tumor necrosis factor-alpha
  ...kade/T-cell suppression with abatacept [Orencia®], B-cell suppression with rituximab [Rituxan®] or IL-6-receptor blockade with tocilizumab [Actemra®])?Most rh
  8 KB (1,138 words) - 02:03, 4 November 2010
• Rheumatoid arthritis
  ..., Emery P, Close DR et al.| title=Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. | journal=N Engl J Med | year= 2004
  38 KB (5,208 words) - 09:02, 1 March 2024